Gapping down
In reaction to disappointing earnings/guidance: WWWW -20.7% (also downgraded to Neutral from Buy at Sun Trust Rbsn Humphrey), SREV -12%, MXWL -9.9%, ADNC -9.8%, CTRL -9.6%, GPRO -9.4%, YRCW -9.3% (light volume), BYD -9.1%, ARRS -7.8%, PXLW -7.2%, IMMR -6.6%, MT -6%, ABTL -4.4%, (light volume), MRC -3.8%, (light volume), SPWR -3.3%, AFFX -2.6%,OUTR -2.2%, PCYC -2.2%, OMG -2.1%, (light volume), RBS -1.9%, LYV -1.7%, GFIG -1.5% (light volume), KOG -0.9%, TSLA -0.6%, ASH -0.6%, WY -0.4%, (light volume).
Select financial related names showing weakness: DB -1.6%, UBS -1.3%, HSBC -1%, C -1% (to sell 80% of its $1.5 bln limited partnership interest in Metalmark Capital Partners II to Lexington ), CS -0.9%, BAC -0.7%, ING -0.6%.
Select metals/mining stocks trading lower: MT -5.9%, GOLD -2.5% (downgraded to Neutral from Buy at UBS), RIO -2.4%, BBL -1.4%, BHP -1.1%.
Select solar names lower following SPWR results: TSL -1.9% JKS -1.1% CSIQ -0.6%.
A few European drug names are trading lower: NVS -3.3%, GSK -1.6%, SHPG -1.1%, AZN -0.7%
Other news: BOTA -21.8% (reports top-line data From its Phase 2 IGLOO trial of Laninamivir Octanoate; neither the 40 mg or 80 mg cohort achieved a statistically significant reduction in the median time to alleviation of influenza symptoms), HIL -10.6% (priced public offering of common stock at $4.25/share after hours; intends to initially keep $10.0 mln of the net proceeds as cash or cash equivalents and to use the balance of the net proceeds from the offering), AIXG -7.3% (pulling back from two day gains), ALU -6.7% (continued weakness following earnings), SSYS -6% (announced that it has expanded European Ops ATHL -3.8% ( prices 12.5 mln share offering by selling shareholders at $46.25 per share ), PT -3.7% (continued weakness), RGSE -3.6% (filed for an offering of ~4.232 mln shares of Class A common stock by selling shareholders), VE -3.4% / SAP -1.9% (still checking), BONE -3.1% (announces public offering of common stock; size not disclosed), YY -2.4% (still checking), MSFT -1.5% (received unfavorable ruling yesterday in Ireland court ruling), RDS.A -1.4% (acknowledged outcome of Woodside Petroleum's shareholders' negative vote on selective buy-back proposal announced June 17 2014; Shell is reviewing its options in relation to its remaining 13.6% holding in Woodside), CDTI -1.3% (promotes David E. Shea to Chief Financial Officer), QIHU -1.3% ( priced private placement of $450 mln principal amount of convertible senior notes due 2020 and $450 mln principal amount of convertible senior notes due 2021), IGT -0.8% (following SGMS / BYI news).
Analyst comments: DDD -3.3% (downgraded to Sector Perform at RBC Capital Mkts; downgraded to Neutral from Overweight at Piper Jaffray, downgraded to Neutral from Buy at Citigroup), EHTH -1.4% (downgraded to Neutral from Buy at BofA/Merrill), BBBY -1.5% (downgraded at Opco).
Select financial related names showing weakness: DB -1.6%, UBS -1.3%, HSBC -1%, C -1% (to sell 80% of its $1.5 bln limited partnership interest in Metalmark Capital Partners II to Lexington ), CS -0.9%, BAC -0.7%, ING -0.6%.
Select metals/mining stocks trading lower: MT -5.9%, GOLD -2.5% (downgraded to Neutral from Buy at UBS), RIO -2.4%, BBL -1.4%, BHP -1.1%.
Select solar names lower following SPWR results: TSL -1.9% JKS -1.1% CSIQ -0.6%.
A few European drug names are trading lower: NVS -3.3%, GSK -1.6%, SHPG -1.1%, AZN -0.7%
Other news: BOTA -21.8% (reports top-line data From its Phase 2 IGLOO trial of Laninamivir Octanoate; neither the 40 mg or 80 mg cohort achieved a statistically significant reduction in the median time to alleviation of influenza symptoms), HIL -10.6% (priced public offering of common stock at $4.25/share after hours; intends to initially keep $10.0 mln of the net proceeds as cash or cash equivalents and to use the balance of the net proceeds from the offering), AIXG -7.3% (pulling back from two day gains), ALU -6.7% (continued weakness following earnings), SSYS -6% (announced that it has expanded European Ops ATHL -3.8% ( prices 12.5 mln share offering by selling shareholders at $46.25 per share ), PT -3.7% (continued weakness), RGSE -3.6% (filed for an offering of ~4.232 mln shares of Class A common stock by selling shareholders), VE -3.4% / SAP -1.9% (still checking), BONE -3.1% (announces public offering of common stock; size not disclosed), YY -2.4% (still checking), MSFT -1.5% (received unfavorable ruling yesterday in Ireland court ruling), RDS.A -1.4% (acknowledged outcome of Woodside Petroleum's shareholders' negative vote on selective buy-back proposal announced June 17 2014; Shell is reviewing its options in relation to its remaining 13.6% holding in Woodside), CDTI -1.3% (promotes David E. Shea to Chief Financial Officer), QIHU -1.3% ( priced private placement of $450 mln principal amount of convertible senior notes due 2020 and $450 mln principal amount of convertible senior notes due 2021), IGT -0.8% (following SGMS / BYI news).
Analyst comments: DDD -3.3% (downgraded to Sector Perform at RBC Capital Mkts; downgraded to Neutral from Overweight at Piper Jaffray, downgraded to Neutral from Buy at Citigroup), EHTH -1.4% (downgraded to Neutral from Buy at BofA/Merrill), BBBY -1.5% (downgraded at Opco).